PTPN6 is reported to show high expression in insulin target tissues in obesity, in which it interacts with P85, resulting in P85 dephosphorylation and reduced AKT phosphorylation in the control of liver metabolism [40, 41]; however, the mechanism is unclear. Here, PIK3R1 is linked to obesity disorder.